Aryan Mishra: β-Thalassemia Analyzer – HPLC for Hemoglobinopathy Screening
Aryan Mishra, Sales Executive at Surana Enterprises, shared a post on LinkedIn:
“β-Thalassemia Analyzer: What Does It Actually Do?
A routine CBC can provide important clues, but evaluating β-thalassemia and other hemoglobinopathies may require detailed hemoglobin analysis.
Many dedicated systems use HPLC (High-Performance Liquid Chromatography) to separate and quantify different hemoglobin fractions.
Blood Sample leads to Separation, followed by Detection, Chromatogram, and Result.
Key parameters such as HbA₂ and HbF can provide valuable information during laboratory evaluation.
Why is this technology important?
- Carrier screening
- HbA₂ and HbF quantification
- Hemoglobin variant analysis
- Hemoglobinopathy screening
- Standardized laboratory workflow
Key takeaway: A diagnostic analyzer isn’t just a machine—it is a tool that helps laboratories generate clinically meaningful information.”
Stay updated with Hemostasis Today.
-
Oct 22, 2026, 17:03Smita Patil: New Insights Into Platelet Alpha-Granule Secretion
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia
-
Oct 22, 2026, 16:36Alissa Odum: Every Blood Type Matters Every Donation Saves Lives
-
Oct 22, 2026, 16:33Mehul Malhotra: Targeted Therapies and Clinical Advances Transform the wAIHA Treatment Landscape
-
Oct 22, 2026, 16:13William Wallace: The Hidden Neurological Impact of Vitamin B12 Deficiency
-
Oct 22, 2026, 16:06Akram Farhadi: Anemia and Low Hemoglobin Associated With Higher Risk of Osteosarcopenia in Older Adults
-
Oct 22, 2026, 15:49Javed Iqbal: NUMC Pulmonary and Critical Care Team Showcases Research at CHEST 2026
-
Oct 22, 2026, 15:37Alina Mitina: Key Concerns Surrounding DVT and Pulmonary Embolism
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges